Given the extreme complexity of tumour heterogeneity, we have not yet demonstrated whether the effect of N137 on tumour EMT is mediated by a direct effect of netrin-1 blockade on cancer cells or whether this effect is due to an indirect effect triggered by changes in the tumour microenvironment. The gene discussed is NTN1; the disease is cancer.